Navigation Links
Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinson's Disease Research Models
Date:10/1/2009

d to facilitate the development of new models that scientists believe will provide a better understanding of Parkinson's disease at the molecular, biochemical, physiological and behavioral levels. This knowledge may, in turn, result in new therapeutic targets and approaches for the treatment of Parkinson's disease.

"Our Foundation's mission is to accelerate the conversion of basic discoveries about Parkinson's disease into practical treatments that will make a difference in patients' lives," said Katie Hood, CEO of The Michael J. Fox Foundation. "To accomplish this, there is a critical need for new research models to more effectively screen potential new therapies, particularly neuroprotective therapies. We're excited about the knockout rat technology developed by Sigma-Aldrich, and hopeful for its prospects to quickly make a major impact on Parkinson's disease drug development efforts and help deliver breakthrough treatments to patients faster."

"The work undertaken and funding provided by The Michael J. Fox Foundation is fundamental to the scientific community's ability to get one step closer to the next generation of Parkinson's disease treatments," added Dr. Edward Weinstein, Director of SAGE Labs at Sigma-Aldrich. "With the power of our CompoZr technology, we are able provide a unique and innovative contribution to furthering research into this debilitating disorder. The models that we are developing may one day help in the development of new therapeutic approaches to a number of diseases. We are excited to have an opportunity to advance scientific understanding in areas that can directly improve the lives of those that suffer with this disease."

Because rats are physiologically similar to humans, they are ideal subjects for modeling human diseases and have been an important species for research in a number of fields including physiology, endocrinology, neurology, toxicology and cancer. Until recently it has been impossible to c
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
4. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
5. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
6. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
7. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
8. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
9. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
10. Families of Spinal Muscular Atrophy Receives FDA Orphan Drug Designation For Quinazoline495 For The Treatment of Spinal Muscular Atrophy
11. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Vasomedical, Inc. (OTC BB: ... the design, manufacture and sale of medical devices and in ... Dr. Jun Ma , President and CEO ... LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hotel. The Company,s presentation is scheduled to ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
(Date:5/21/2013)... 2013 Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Martin Mulroy , chief commercial ... & Veterinary Conference on Wednesday, May 29, 2013 at ... Le Parker Meridien Hotel in New York ... Abaxis develops, manufactures, markets and sells portable blood analysis ...
Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
... NEW HAVEN, Conn., Aug. 5 Rib-X ... company focused on the,discovery and development of ... announced today that company,representatives are giving three ... Research Conference on Medicinal Chemistry, August 3-8, ...
... Aug. 5 Nexgen Spine, a leading,developer of ... disc disease, announced today that it has received ... Disc in the European,Union., "We are delighted ... mark approval," said Alastair Clemow, Ph.D., President and ...
Cached Medicine Technology:Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 3Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
(Date:5/21/2013)... Journal of the Pediatric Infectious Diseases Society ... issue, which includes a consensus statement of the ... It establishes standardized definitions, measurements, and other key ... the first step as the group of international ... and resources that can improve children,s access to ...
(Date:5/21/2013)... 2013 Children with autism showed significant improvement after ... everyday items such as scents, spoons and sponges, according ... treatment known as environmental enrichment led to notable gains ... 12. Results appear online in Behavioral Neuroscience . ... assigned 28 boys to one of two groups, balanced ...
(Date:5/21/2013)... Human Reproduction & Embryology) is now the world,s leading ... expected this year, presenting a wealth of new research ... public interest. Reports from proceedings of the ESHRE congress ... , This year,s event will be held at the ... July. , The scientific programme for this year,s event ...
(Date:5/21/2013)... 21, 2013 Children using the ... Inc., experience audiological results comparable to the traditionally ... fewer complications, according to a new study. , ... Sophono’s abutment-free technology performs just as well as ... many fewer complications,” says Jim Kasic, president and ...
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud and ... the featured company in an impact report written and ... Bets on Converged Cloud Integration and Process-Orchestration Suites,” offers ... pricing, customers and competition. , “For organizations ... and process orchestration, especially when price, ease of use ...
Breaking Medicine News(10 mins):Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 2Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 3Health News:Enrichment therapy effective among children with autism, UCI study finds 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Adeptia Featured in Recent 451 Research Impact Report 2
... Revenue, Net ... MICROS Systems, Inc.,(Nasdaq: MCRS ), a leading supplier of information ... its,fiscal 2008 first quarter ended September 30, 2007. FINANCIAL HIGHLIGHTS, ... of $42.8 million, or 24.6%, over the ...
... wrigglers, orientation , THURSDAY, Oct. 25 (HealthDay News) -- ... worms called nematodes, say scientists who genetically manipulated some ... same sex. , The finding might give some insight ... conclusions are narrow in that they are about worms ...
... Partners with Osiris on a Phase II Trial to ... Diabetes , New York, NY October ... today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to ... immunomodulatory cell therapy product, to preserve and regenerate insulin-producing ...
... Result of Alliance with Dr. James Levine of ... Steelcase Inc. (NYSE: SCS ),a global ... workstation with an integrated treadmill, at its New,York ... from the,FitWork(TM) category of products designed to bring ...
... In its first-ever,single-topic special issue, the Harvard Heart ... advice aimed at unscrambling the mixed,messages about what ... nutrition, its recommendations include:, -- You can,t ... exercise,fruits and vegetables are the closest thing we ...
... snacking and mobile devices more appetizing than sit-down ... increasingly are,attached to portable devices such as laptops, ... eat-and-run mode. According to a,recent survey(1) conducted for ... ), nearly one in three Americans ages 18-34,has ...
Cached Medicine News:Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2Health News:JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes 2Health News:Steelcase Unveils the Walkstation to Bring Healthy Habits to The Workplace 2Health News:Steelcase Unveils the Walkstation to Bring Healthy Habits to The Workplace 3Health News:All About Heart-Healthy Eating: The Harvard Heart Letter Devotes an Issue to Nutrition 2Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 2Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: